Evidence map›Paper›PMID 35684021›Full record

Trial reportNutrients2022

A Combination of Nicotinamide and D-Ribose (RiaGev) Is Safe and Effective to Increase NAD

Yongquan Xue, Trisha Shamp, G A Nagana Gowda, Michael Crabtree, Debasis Bagchi, Daniel Raftery

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Regulation of and challenges in targeting NADNature reviews. Molecular cell biology · 2024
    Review
  5. Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. A new limit for blood metabolite analysis usingJournal of magnetic resonance open · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Yongquan XueBioenergy Life Science, Inc., Ham Lake, MN 55304, USA.ORCID 0000-0002-7388-6899
Trisha ShampPrism Clinical Research Institute, Saint Paul, MN 55114, USA.
G A Nagana GowdaNorthwest Metabolomics Research Center, University of Washington, Seattle, WA 98109, USA.ORCID 0000-0002-0544-7464
Michael CrabtreeBioenergy Life Science, Inc., Ham Lake, MN 55304, USA.
Debasis BagchiCollege of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.
Daniel RafteryNorthwest Metabolomics Research Center, University of Washington, Seattle, WA 98109, USA.ORCID 0000-0003-2467-8118
Bioenergy Life Science (United States) · USUniversity of Washington · USClinical Research Institute · USTexas Southern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotinamide adenine dinucleotide (NAD

Indexed as

NADNiacinamideAdultHumansMetabolomeMiddle AgedPilot ProjectsRiboseNADNiacinamideRiboseagingcortisolD-riboseenergy homeostasisnicotinamide adenine dinucleotide (NAD+)oxidative stressvitamin B3

Identifiers

PMID35684021
PMCPMC9183138
OpenAlexW4281981300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.